Zydus Wellness share news, announcements and annual reports
NSE: ZYDUSWELLBSE: 531335Food ProductsSmall Cap
Share price at the NSE close on 2 Nov 2026. Previous close ₹462.75.
2 Nov: open ₹460.50, high ₹486.85, low ₹456.00
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹15,377 Cr434th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 81.70
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹41 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 67.15
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.25%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 3.3%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹41 crore of one-off items, the largest of them in the quarter to Sep 2025.
- 4.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 4.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.55
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 82,92642.0% delivered
Zydus Wellness share news and announcements
706 announcements, routine notices left out, newest first. Page 13 of 15.
Aug 2015
Jul 2015
30 Jul · Disclosure of Voting Pattern - Clause 35A
30 Jul · Disclosure of Voting Pattern - Clause 35A
Jun 2015
15 Jun · Legal
Spurt in Volume : Substantial increase in trading volumes have been observed in Zydus Wellness Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Zydus Wellness Limited has vide its letter inter-alia stated, "There is no information / announcement from the Company that is required to be intimated to the Stock Exchanges pursuant to clause 36 of the Listing Agreement, which may have bearing on the volume behaviour in the Company's scrip."
May 2015
19 May · Code of Conduct under SEBI(PIT) Reg., 2015
14 May · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from July 20, 2015 to July 29, 2015 (both days inclusive) for the purpose of Dividend and Annual General Meeting (AGM) of the Company to be held on July 29, 2015.
Apr 2015
27 Apr · Board meeting
To consider apart from other agenda items to approve the audited financial results for the quarter / year ended on March 31, 2015 and to recommend dividend on equity shares of the Company for the year ended on March 31, 2015.
Feb 2015
Jan 2015
20 Jan · Board meeting
To consider apart from other agenda items to approve the unaudited financial results [limited reviewed] for the quarter / nine months ended on December 31, 2014.
Dec 2014
Nov 2014
Oct 2014
14 Oct · Board meeting
To consider apart from other agenda items to approve the unaudited financial results for the quarter / half year ended on September 30, 2014. Further, as per the Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI [Prohibition of Insider Trading] Regulations, 1992, the Trading Window will remain closed from October 26, 2014 to November 06, 2014 for all Directors and Designated Officers of the Company.
Sep 2014
10 Sep · Legal
Exchange has sought clarification from Zydus Wellness Limited with respect to a news item captioned "Novartis files lawsuit against Zydus". The Company has clarified that "this matter pertains to Zydus Wellness Limited. In fact this matter is related to Cadila Healthcare Limited, which is a flagship Company of Zydus Cadila Group of Companies. The matter pertains to the filing of a product by the Company with USFDA for getting an approval of the same for marketing in the US market. When any Company files the product on the ground that the patent of the present patent holder is either not valid or is not infringed, it is normally expected that the patent holder will challenge the claim of the Company. For many listed Indian Pharma Companies having marketing in the US territory this is an usual matter. There is no material impact on the Company at all because this pertains to the products which are applied for approval and are not presently sold in US market. No other disclosures are required, as it is a routine process".
Jul 2014
16 Jul · Disclosure of Voting Pattern - Clause 35A
Jun 2014
May 2014
5 May · Board meeting
Inter alia, to consider to approve the audited financial results for the quarter / year ended March 31, 2014 and to recommend dividend on equity shares of the Company for the year ended on March 31, 2014. Further, as per code of conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992, the Trading Window will remain close from May 08, 2014 to May 16, 2014 for all Directors and Designated Officers of the Company.
Feb 2014
Jan 2014
20 Jan · Board meeting
To consider amongst other agenda items to approve the unaudited financial results for the quarter / nine months ended on December 31, 2013. Further, as per code of conduct for prevention of insider trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulation, 1992, the trading Window will remain close from January 28, 2014 to February 07, 2014 for all Directors and Designated Officers of the Company.
Nov 2013
18 Nov · Address Change
Pursuant to the resolution passed by the Board of Directors at their meeting held on October 30, 2013, the Registered Office of the Company is shifted w.e.f. October 30, 2013 from Zydus Tower, Satellite Cross Roads, Sarkhej-Gandhinagar Highway, Ahmedabad-380015 to House No. 6 &7, Sigma Commerce Zone, Nr. Iscon temple, Sarkhej-Gandhinagar Highway, Ahmedabad-380015.
Oct 2013
30 Oct · Results
15 Oct · Board meeting
To consider apart from other agenda items the unaudited financial results for the quarter / half year ended on September 30, 2013.
Sep 2013
Aug 2013
8 Aug · Disclosure of Voting Pattern - Clause 35A
Jul 2013
23 Jul · Board meeting
To consider apart from other agenda items the unaudited financial results for the quarter ended on June 30, 2013.
Jun 2013
3 Jun · Management
Existing auditors - M/s. Manubhai & Co., Chartered Accountants have expressed their unwillingness to be re-appointed at the ensuing Annual General Meeting. In the circumstances, the members of the Audit Committee and the Board vide circular resolution have recommended to the members the appointment of M/s. Dhirubhai Shah & Co., Chartered Accountants, Ahmedabad as the Statutory Auditors of the Company at the ensuing Annual General Meeting.
May 2013
13 May · Dividend
Board of Directors of the Company at its meeting held on May13, 2013, has declared interim dividend @ 60% i.e. Rs. 6/- per Equity Share on 3,90,72,089 Equity Shares of Rs. 10/- each of the Company for the year ended on March 31, 2013.13 May · Corporate action
Company has fixed Record Date as May 23, 2013 for the purpose of to ascertain the eligibility of the members entitled to receive the interim Dividend, declared by the Board of Directors.